Cosmo Pharmaceuticals
C43.F
$80.32
Share price
0.67%
Change (1 day)
31.65%
Change (1 year)
Categories
Revenue for Cosmo Pharmaceuticals (C43.F)
Revenue in 2022: $0.10 B
According to Cosmo Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.10 B. In 2022 the company made a revenue of $0.10 B an increase over the years 2021 revenue that were of $73.69 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cosmo Pharmaceuticals from 2004 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | $0.10 B | 48.36% |
| 2021 | $73.69 M | -1.69% |
| 2020 | $74.96 M | 7.08% |
| 2019 | $70 M | -6.74% |
| 2018 | $75.06 M | -7.01% |
| 2017 | $80.72 M | 13.33% |
| 2016 | $71.22 M | 7.49% |
| 2015 | $66.26 M | -31.54% |
| 2014 | $96.8 M | 24.35% |
| 2013 | $77.84 M | -1.15% |
| 2012 | $78.75 M | 81.34% |
| 2011 | $43.42 M | 1.87% |
| 2010 | $42.63 M | 11.51% |
| 2009 | $38.23 M | -19.97% |
| 2008 | $47.77 M | 49.4% |
| 2007 | $31.97 M | 59.58% |
| 2006 | $20.03 M | 9.35% |
| 2005 | $18.32 M | 22.46% |
| 2004 | $14.96 M |